How Your Brain’s Nightly Cleanse Keeps It Healthy (Links to an external site)
Washing waste from the brain is an essential function of sleep—and it could help ward off dementia
Drug to slow Alzheimer’s well tolerated outside of clinical trial setting (Links to an external site)
Side effects of lecanemab are manageable, study finds
New blood test diagnoses Alzheimer’s disease and measures how far it’s progressed (Links to an external site)
The new test could also help confirm whether Alzheimer’s or another condition is causing a person’s symptoms.
Predicting cognitive decline in Alzheimer’s (Links to an external site)
New tests of blood and spinal fluid can show how far Alzheimer’s has progressed and how fast a patient’s memory will decline.
Can a Drug Prevent Alzheimer’s Disease Decades Before It Happens? (Links to an external site)
Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer’s.
New drug targets for Alzheimer’s identified from cerebrospinal fluid (Links to an external site)
Study pegs certain cellular activities to driving Alzheimer’s disease. Researchers at Washington University School of Medicine in St. Louis have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and progression.
The New Age of Alzheimer’s (Links to an external site)
The soaring burden of dementia threatens global health. Science is paving new paths to solutions.
Podcast: Newly approved drug may slow progression of Alzheimer’s (Links to an external site)
Lilly drug slows Alzheimer’s by 35%, bolstering treatment approach (Links to an external site)
Conquering Alzheimer’s: a look at the therapies of the future (Links to an external site)
Focused ultrasound technique leads to release of neurodegenerative disorders biomarkers (Links to an external site)
FDA APPROVES LEQEMBI™ (LECANEMAB-IRMB) UNDER THE ACCELERATED APPROVAL PATHWAY FOR THE TREATMENT OF ALZHEIMER’S DISEASE (Links to an external site)
WashU, Eisai form drug discovery collaboration (Links to an external site)
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III GRADUATE programme evaluating gantenerumab in early Alzheimer’s disease (Links to an external site)
LECANEMAB CONFIRMATORY PHASE 3 CLARITY AD STUDY MET PRIMARY ENDPOINT, SHOWING HIGHLY STATISTICALLY SIGNIFICANT REDUCTION OF CLINICAL DECLINE IN LARGE GLOBAL CLINICAL STUDY OF 1,795 PARTICIPANTS WITH EARLY ALZHEIMER’S DISEASE (Links to an external site)
Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease (Links to an external site)
Blood test for Alzheimer’s highly accurate in large, international study (Links to an external site)
Dementia First blood test to help diagnose Alzheimer’s goes on sale (Links to an external site)
Why Didn’t She Get Alzheimer’s? The Answer Could Hold a Key to Fighting the Disease (Links to an external site)
‘Reports of My Death Are Greatly Exaggerated.’ Signed, Aducanumab (Links to an external site)
The importance of prevention trials in Alzheimer’s disease with Randall Bateman (Links to an external site)
Blood test is highly accurate at identifying Alzheimer’s before symptoms arise (Links to an external site)
